Registrational Phase 3 study for advanced melanoma immunotherapy delivered with PharmaJet's IM Needle-free System planned for ...
News-Medical.Net on MSN
Self-administered injectable contraceptives face provider hesitancy despite availability
Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new ...
Preliminary Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth ...
A study reveals that many clinicians remain unaware of self-administered injectable contraception, despite its decades-long availability. Self-administered injectable contraceptives have been an ...
Oclaiz is a subcutaneous long-acting octreotid depot, designed for optimized disease control and convenient self-administration. The product is based on Camurus' FluidCrystal technology and is ...
Zurich, Zurich - January 06, 2026 - PRESSADVANTAGE - Perfect Esthetics, a Zurich-based aesthetic medicine clinic, ...
Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new study has found only about a ...
ScinoPharm Taiwan (TWSE: 1789) today announced a landmark achievement in the global pharmaceutical landscape, securing U.S. Food ...
Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new ...
In April 2025, CMG Pharmaceutical, a subsidiary of CHA Biotech, secured FDA approval for Mezofy (formerly Depipzo), an oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback